303 related articles for article (PubMed ID: 16609012)
41. [Radiation sensitizing effect of anti HPV16E6-ribozyme on cervical carcinoma cell line].
Rao ZG; Zhang JR; Zheng YF; Zhou H; Qu LH
Ai Zheng; 2002 Feb; 21(2):149-52. PubMed ID: 12479064
[TBL] [Abstract][Full Text] [Related]
42. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer.
Jonson AL; Rogers LM; Ramakrishnan S; Downs LS
Gynecol Oncol; 2008 Nov; 111(2):356-64. PubMed ID: 18755502
[TBL] [Abstract][Full Text] [Related]
43. Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis.
Yuan H; Fu F; Zhuo J; Wang W; Nishitani J; An DS; Chen IS; Liu X
Oncogene; 2005 Jul; 24(32):5069-78. PubMed ID: 15856013
[TBL] [Abstract][Full Text] [Related]
44. HPV16 E6 and E7 oncoproteins regulate Notch-1 expression and cooperate to induce transformation.
Weijzen S; Zlobin A; Braid M; Miele L; Kast WM
J Cell Physiol; 2003 Mar; 194(3):356-62. PubMed ID: 12548555
[TBL] [Abstract][Full Text] [Related]
45. [Effects of anti-HPV16 E6-ribozyme on invasiveness of cervical carcinoma cell line CaSKi and vascular endothelial growth factor expression].
Liu K; Wang LL; Zheng YF; Zhang JR
Di Yi Jun Yi Da Xue Xue Bao; 2004 May; 24(5):529-32. PubMed ID: 15151824
[TBL] [Abstract][Full Text] [Related]
46. [The inhibitory effects of siRNA expression vector on the expression of human papillomavirus E6 gene].
Li DK; Peng ZL; Niu XY; Wang DQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):331-3. PubMed ID: 15931860
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes.
Gu W; Putral L; Hengst K; Minto K; Saunders NA; Leggatt G; McMillan NA
Cancer Gene Ther; 2006 Nov; 13(11):1023-32. PubMed ID: 16810314
[TBL] [Abstract][Full Text] [Related]
48. [Inhibitory effect of bladder cancer related protein gene on HeLa cell proliferation].
Zuo ZH; Zhao M; Liu J; Wei Y; Wu XX
Ai Zheng; 2006 Jul; 25(7):811-7. PubMed ID: 16831269
[TBL] [Abstract][Full Text] [Related]
49. Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo.
Liao S; Deng D; Zhang W; Hu X; Wang W; Wang H; Lu Y; Wang S; Meng L; Ma D
Oncol Rep; 2013 Jan; 29(1):95-102. PubMed ID: 23128977
[TBL] [Abstract][Full Text] [Related]
50. Apicidin down-regulates human papillomavirus type 16 E6 and E7 transcripts and proteins in SiHa cervical cancer cells.
Luczak MW; Jagodzinski PP
Cancer Lett; 2008 Dec; 272(1):53-60. PubMed ID: 18687520
[TBL] [Abstract][Full Text] [Related]
51. Effects of anti-HPV16E6-ribozyme on phenotype and gene expression of a cervical cancer cell line.
Zheng Y; Zhang J; Qu L
Chin Med J (Engl); 2002 Oct; 115(10):1501-6. PubMed ID: 12490096
[TBL] [Abstract][Full Text] [Related]
52. Altered growth and viral gene expression in human papillomavirus type 16-containing cancer cell lines treated with progesterone.
Yuan F; Auborn K; James C
Cancer Invest; 1999; 17(1):19-29. PubMed ID: 10999045
[TBL] [Abstract][Full Text] [Related]
53. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
Riezebos-Brilman A; Walczak M; Regts J; Rots MG; Kamps G; Dontje B; Haisma HY; Wilschut J; Daemen T
Gene Ther; 2007 Dec; 14(24):1695-704. PubMed ID: 17928874
[TBL] [Abstract][Full Text] [Related]
54. Effects of anti-HPV16 E6-ribozyme on the proliferation and apoptosis of human cervical cancer cell line CaSKi.
Zheng YF; Rao ZG; Zhang JR
Di Yi Jun Yi Da Xue Xue Bao; 2002 Jun; 22(6):496-8. PubMed ID: 12297466
[TBL] [Abstract][Full Text] [Related]
55. TGF-beta1 and IL-4 downregulate human papillomavirus-16 oncogene expression but have differential effects on the malignant phenotype of cervical carcinoma cells.
Donalisio M; Cornaglia M; Landolfo S; Lembo D
Virus Res; 2008 Mar; 132(1-2):253-6. PubMed ID: 18206261
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of cervical cancer cell growth in vitro and in vivo with dual shRNAs.
Gu W; Payne E; Sun S; Burgess M; McMillan NA
Cancer Gene Ther; 2011 Mar; 18(3):219-27. PubMed ID: 21102424
[TBL] [Abstract][Full Text] [Related]
57. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
58. [Effect of anti-HPV16 E6-ribozyme on cell proliferation and invasiveness of cervical carcinoma cell line CaSKi].
Liu K; Wang LL; Sun F; Zheng YF; Zhang JR
Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec; 24(12):1367-72. PubMed ID: 15604060
[TBL] [Abstract][Full Text] [Related]
59. Vaccination with an adenoviral vector expressing calreticulin-human papillomavirus 16 E7 fusion protein eradicates E7 expressing established tumors in mice.
Gomez-Gutierrez JG; Elpek KG; Montes de Oca-Luna R; Shirwan H; Sam Zhou H; McMasters KM
Cancer Immunol Immunother; 2007 Jul; 56(7):997-1007. PubMed ID: 17146630
[TBL] [Abstract][Full Text] [Related]
60. [Inhibiting E7 oncogene in CaSki cells of cervical cancer by vector-based RNA interference technique].
Wang DQ; Peng ZL; Niu XY; Li DK
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):6-8, 48. PubMed ID: 17294716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
